Product NDC: | 0093-4030 |
Proprietary Name: | Indomethacin |
Non Proprietary Name: | Indomethacin |
Active Ingredient(s): | 50 mg/1 & nbsp; Indomethacin |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-4030 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA070756 |
Marketing Category: | ANDA |
Start Marketing Date: | 20071214 |
Package NDC: | 0093-4030-01 |
Package Description: | 100 CAPSULE in 1 BOTTLE (0093-4030-01) |
NDC Code | 0093-4030-01 |
Proprietary Name | Indomethacin |
Package Description | 100 CAPSULE in 1 BOTTLE (0093-4030-01) |
Product NDC | 0093-4030 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Indomethacin |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20071214 |
Marketing Category Name | ANDA |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | INDOMETHACIN |
Strength Number | 50 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |